VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632 | -63.1% | 67,442 | -3.4% | 0.00% | -66.7% |
| Q2 2023 | $1,712 | +5.5% | 69,784 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,623 | -19.0% | 69,784 | -11.9% | 0.00% | -40.0% |
| Q4 2022 | $2,003 | -99.9% | 79,168 | -7.2% | 0.01% | +25.0% |
| Q3 2022 | $1,644,000 | -23.9% | 85,298 | +0.6% | 0.00% | -33.3% |
| Q2 2022 | $2,159,000 | -1.0% | 84,775 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $2,180,000 | -39.2% | 84,775 | -1.0% | 0.01% | -37.5% |
| Q4 2021 | $3,584,000 | -5.6% | 85,620 | -1.9% | 0.01% | -20.0% |
| Q3 2021 | $3,796,000 | -27.2% | 87,241 | -20.9% | 0.01% | -23.1% |
| Q2 2021 | $5,216,000 | +13.8% | 110,329 | +23.4% | 0.01% | 0.0% |
| Q1 2021 | $4,584,000 | +16.6% | 89,428 | -39.1% | 0.01% | +8.3% |
| Q4 2020 | $3,931,000 | -22.3% | 146,804 | -0.3% | 0.01% | -29.4% |
| Q3 2020 | $5,057,000 | -22.6% | 147,318 | -7.6% | 0.02% | -32.0% |
| Q2 2020 | $6,532,000 | – | 159,439 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |